kabutan

ROHTO PHARMA, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Highest in Two Terms

Wed Aug 6, 2025 3:30 pm JST Earnings

4527 ROHTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ROHTO PHARMACEUTICAL CO.,LTD. <4527> [TSE Prime] announced its financial results after the market closed on August 6th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) expanded 16.1 billion yen, an increase 31.4% compared to the same period last year.

In addition, the full-year forecast for consolidated ordinary profit has been revised upward 6.2%, from the previous forecast of 40.5 billion yen to 43.0 billion yen (compared to 40.4 billion yen in the previous period), increasing the growth rate from 0.2% to 6.4%, reaches new record high for the first time in two terms.

In the most recent three-month period, from April to June (1Q), the operating profit margin decreased from 17.2% in the same period last year to 14.3%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Jun, 2023 61,171 11,292 12,242 9,090 39.9 54.0 Aug 9, 2023 J-GAAP
Apr - Jun, 2024 68,356 11,790 12,273 8,482 37.2 66.0 Aug 7, 2024 J-GAAP
Apr - Jun, 2025 81,964 11,699 16,127 11,769 52.1 ー Aug 6, 2025 J-GAAP
YoY +19.9% -0.8% +31.4% +38.8% +40.1%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 334,500 39,000 40,500 31,100 137.6 42 May 13, 2025 J-GAAP
Mar, 2026 New 334,500 39,000 43,000 31,500 139.4 42 Aug 6, 2025 J-GAAP
Revision Rate 0.0% 0.0% +6.2% +1.3% +1.3%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 139,082 17,791 18,590 12,921 56.6 16 Nov 13, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 21 May 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 270,840 40,048 42,434 30,936 135.6 27 May 13, 2024 J-GAAP
Mar, 2025 308,625 38,939 40,430 31,006 136.1 36 May 13, 2025 J-GAAP
Mar, 2026 Guidance 334,500 39,000 43,000 31,500 139.4 42 Aug 6, 2025 J-GAAP
YoY +8.4% +0.2% +6.4% +1.6% +2.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 68,356 11,790 12,273 8,482 37.2 17.2 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 70,726 6,001 6,317 4,439 19.5 8.5 Nov 13, 2024 J-GAAP
Oct - Dec, 2024 86,813 14,476 14,793 11,885 52.1 16.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 82,730 6,672 7,047 6,200 27.2 8.1 May 13, 2025 J-GAAP
Apr - Jun, 2025 81,964 11,699 16,127 11,769 52.1 14.3 Aug 6, 2025 J-GAAP
YoY +19.9% -0.8% +31.4% +38.8% +40.1%

Related Articles